Genetic lottery makes common chemo drugs deadly – Why do doctors skip testing first

(NaturalHealth365)  The FDA just issued a stark warning that should terrify every cancer patient.  In a safety announcement released this year, the agency finally acknowledged what researchers have been screaming about for years: certain chemotherapy drugs can be lethal for patients with genetic variants, and doctors need to start discussing testing options before treatment begins.

But here’s the kicker – even with this official warning, the FDA still only says providers “should consider” testing, not that they must do it.  Meanwhile, every year around 300,000 Americans receive these potentially deadly chemotherapy drugs called fluoropyrimidines – medications like 5-fluorouracil and capecitabine that have been cancer treatment mainstays for over 60 years.

What most patients still don’t know is that roughly 1 in 25 people carries genetic variants that make these drugs potentially lethal.  Research published in The Oncologist has quantified just how dangerous this genetic lottery can be. A comprehensive analysis of nearly 14,000 patients found that people with certain DPYD gene variants face a staggering 25.6 times higher risk of treatment-related death when given standard doses of these chemotherapy drugs.

The FDA’s new labeling requirements acknowledge that “no dose has been proven safe for patients with complete DPD deficiency” and that even patients with partial deficiency “may have increased risk of serious, including fatal, adverse reactions.”  Yet despite this admission and mounting evidence, most oncologists still don’t routinely test patients before prescribing these medications.  The result?

Approximately 1,300 Americans die each year not from cancer, but from chemotherapy drugs that could have been safely adjusted or avoided entirely.

The enzyme that determines life or death

The DPYD gene regulates the production of an enzyme called dihydropyrimidine dehydrogenase (DPD), which breaks down over 80% of fluorouracil in the body.  Think of this enzyme as your body’s chemical disposal system for these powerful cancer drugs.

When someone has defective variants of the DPYD gene, their body can’t properly eliminate these medications.  The drugs accumulate to toxic levels, causing severe reactions including mucositis, diarrhea, dangerous drops in white blood cells, nerve damage, and in the worst cases, death.

The research identified four specific genetic variants that create the highest risk.  Patients carrying these variants had treatment-related mortality rates of 2.3% to 3.7%, compared to just 0.1% in patients without the variants.  For some of the more severe variants, the death rate approached 1 in 25 patients.

A simple test that could save thousands of lives

What makes this situation particularly tragic is how preventable these deaths are.  Genetic testing for DPYD variants costs less than $300 and takes just a few days to complete.  Once doctors know a patient carries risky variants, they have several options:

• Switch to alternative chemotherapy drugs that don’t rely on DPD enzyme function
• Start with significantly reduced doses and monitor carefully
• Use closer monitoring protocols to catch toxicity early

The FDA even approved an antidote called uridine triacetate in 2015 specifically for fluoropyrimidine overdoses and severe toxicity.  In clinical trials, 96% of patients who received this antidote within 96 hours survived.  Yet, these lifesaving interventions remain underutilized because many patients never undergo testing in the first place.

The medical establishment moves at a glacial pace

Despite mounting evidence about these genetic risks, medical institutions have been slow to adopt routine testing.  The National Comprehensive Cancer Network (NCCN), whose guidelines shape oncology practice nationwide, has only recently begun recommending that doctors “consider” testing, rather than requiring it.

Some of the hesitation stems from uncertainty about how to adjust doses for patients with partial enzyme deficiency.  But this argument increasingly rings hollow when the alternative may be death from preventable toxicity.

European regulators have been more aggressive, urging oncologists to test patients since 2020 and recommending that those with risky genetics start on half-doses.  The approach has proven both safe and effective at reducing toxicity while maintaining cancer treatment efficacy.

The economics of prevention vs. tragedy

The contrast between prevention and consequence is stark from both human and economic perspectives.  A $300 genetic test could prevent not just death, but the enormous costs associated with treating severe chemotherapy toxicity.

Patients who develop severe fluoropyrimidine toxicity often require weeks of hospitalization, intensive supportive care, and expensive treatments to manage complications like severe infections from compromised immune systems.  The antidote alone costs thousands of dollars and must be obtained through emergency protocols.

Meanwhile, the genetic test that could prevent these tragedies costs less than many routine medical procedures and can be done with a simple blood draw.

Natural protection strategies that actually work

While genetic testing remains the most important intervention, researchers have discovered several ways to help both prevent cancer and reduce treatment complications:

Start with your cells: Cancer typically begins when cells become damaged and lose their ability to repair themselves properly.  Vitamin C, vitamin E, and glutathione can help stop harmful molecules before they can damage your DNA.  Studies show these nutrients may also help people handle chemotherapy without reducing its effectiveness.

Support your body’s detoxification systems: Your liver does double duty – it breaks down chemo drugs while also clearing out cancer-causing toxins from your environment.  Things like milk thistle, N-acetyl cysteine, and alpha-lipoic acid give your liver extra help with this massive workload.

Strengthen your immune system: Your immune system hunts down abnormal cells every single day.  When it’s working properly, cancer cells get eliminated before they can multiply.  This surveillance becomes crucial if you’re genetically vulnerable to drug toxicity or already fighting cancer.

Protect your gut: Here’s something most people miss – about 70% of your immune system lives in your intestines.  Chemotherapy destroys the helpful bacteria that keep this system functioning.  Probiotics and gut-healing nutrients help maintain your defenses when you can least afford to lose them.

Clean up your environment: Cancer rarely happens overnight.  It’s usually the result of years of toxic exposure that overwhelms your body’s ability to cope.  Learning how to reduce exposure and boost your natural detoxification processes can help prevent problems before they arise.

Get your nutrition right: If you have genetic enzyme problems, you might struggle to maintain proper nutrition during treatment.  However, a clean, organic diet also helps prevent cancer in the first place.  This becomes non-negotiable if you’re already at higher risk.

The bigger problem

This article reveals a disturbing aspect of Western medicine: there is often a significant gap between what science knows and what is implemented.  When lifesaving tools exist but are not used, patients suffer the consequences.

The same pattern happens with cancer prevention.  Most doctors focus on treating cancer after it develops rather than using proven strategies that could stop it from happening.

Jonathan Landsman’s Stop Cancer Docu-Class brings together 22 world-renowned experts who understand that preventing cancer requires more than crossing your fingers and hoping for the best – it necessitates proven strategies that address genetic risks, environmental threats, immune optimization, and cellular protection, which could save your life before cancer takes hold.

Sources for this article include:

NIH.gov
Kffhealthnews.org
Childrenshealthdefense.org
FDA.gov
NIH.gov
NIH.gov
Mayoclinic.org

The post Genetic lottery makes common chemo drugs deadly – Why do doctors skip testing first appeared first on NaturalHealth365.

Visit Natural Health 365 Here /

Source: https://www.naturalhealth365.com/genetic-lottery-makes-common-chemo-drugs-deadly-why-do-doctors-skip-testing-first.html